Literature DB >> 17312058

1H MR spectroscopy in the assessment of gliomatosis cerebri.

Juan A Guzmán-de-Villoria1, Javier Sánchez-González, Lucia Muñoz, Santiago Reig, Carlos Benito, Pedro García-Barreno, Manuel Desco.   

Abstract

OBJECTIVE: Gliomatosis cerebri is a rare brain tumor with a short survival time; for this reason, it is difficult to establish the degree of aggressivity in vivo. The MR spectroscopic findings on this tumor often do not agree with choline level. The purpose of this study was to evaluate whether MR spectroscopy can be used to measure tumor choline levels and whether the findings give useful information about tumor growth rate and patient survival time. SUBJECTS AND METHODS: We performed MRI and 1H MR spectroscopic studies on seven treatment-naive patients with gliomatosis cerebri and on 16 healthy volunteers. We then analyzed the association between survival time and levels of choline (Cho) and N-acetyl aspartate (NAA) normalized to creatine (Cr).
RESULTS: The results showed a statistically significant (p = 0.05) inverse relation between Cho/Cr ratio and survival time. In addition, NAA/Cr ratio was significantly lower in the patient group than in the control group (p = 0.001).
CONCLUSION: Cho/Cr ratio measured with MR spectroscopy seems to be related to survival time, possibly explaining the inconsistent findings previously reported for this parameter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312058     DOI: 10.2214/AJR.06.0055

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

1.  Incidence and survival of gliomatosis cerebri: a population-based cancer registration study.

Authors:  Marios K Georgakis; Dimitrios Spinos; Apostolos Pourtsidis; Amanda Psyrri; Ioannis G Panourias; Spyridon Sgouros; Eleni Th Petridou
Journal:  J Neurooncol       Date:  2018-02-20       Impact factor: 4.130

2.  Gliomatosis cerebri: a review.

Authors:  Roberta Rudà; Luca Bertero; Marc Sanson
Journal:  Curr Treat Options Neurol       Date:  2014-02       Impact factor: 3.598

Review 3.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

4.  Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data.

Authors:  Marios K Georgakis; Georgios Tsivgoulis; Dimitrios Spinos; Nikolaos G Dimitriou; Athanasios P Kyritsis; Ulrich Herrlinger; Eleni Th Petridou
Journal:  J Neurooncol       Date:  2018-08-16       Impact factor: 4.130

5.  Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.

Authors:  Tomoo Inoue; Toshihiro Kumabe; Masayuki Kanamori; Yukihiko Sonoda; Mika Watanabe; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2011-02-08       Impact factor: 3.042

6.  Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas.

Authors:  Sanjeev Chawla; Seung-Cheol Lee; Suyash Mohan; Sumei Wang; MacLean Nasrallah; Arastoo Vossough; Jaroslaw Krejza; Elias R Melhem; S Ali Nabavizadeh
Journal:  Neuroradiol J       Date:  2019-05-03

7.  (1)H MR Spectroscopy in Gliomatosis: Is there a Sensitivity Issue?

Authors:  M Szewczyk-Bieda; A K Kanodia; G Main; M S Eljamel
Journal:  Case Rep Radiol       Date:  2011-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.